Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice

Pflugers Archiv European Journal of Physiology

Volumn 446, Issue 4, 2003, Pages 429-436

  Marano, Giuseppe ^a   Palazzesi, Sergio ^a   Vergari, Alessandro ^b   Catalano, Liviana ^a   Gaudi, Simona ^a   Testa, Claudia ^a   Canese, Rossella ^a   Carpinelli, Giulia ^a   Podo, Franca ^a   Ferrari, Alberto U ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Aortic banding; Cardiac hypertrophy; Cine MRI; Propranolol; Systolic function

Indexed keywords

PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENETIC MANIPULATION; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART VENTRICLE REMODELING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; SYSTOLIC BLOOD PRESSURE;

ANIMALS; AORTA; ECHOCARDIOGRAPHY; HEMODYNAMIC PHENOMENA; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED STRAINS; PROPRANOLOL; SYSTOLE; VASODILATOR AGENTS; VENTRICULAR REMODELING;

EID: 10744222656     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00424-003-1059-2     Document Type: Article

References (10)

1. G-nitro-L-arginine methyl ester-induced hypertension: novel molecular adaptation to systolic load in absence of hypertrophy. Circulation 101:423-429
2. Esposito G, Rapacciuolo A, Naga Prasad SV, Takaoka H, Thomas SA, Koch WJ, Rockman HA (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105:85-92
3. Hill JA, Karimi M, Kutschke W, Davisson RL, Zimmerman K, Wang Z, Kerber RE, Weiss RM (2000) Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 101:2863-2869
4. Marano G, Palazzesi S, Fadda A, Vergari A, Ferrari AU (2002) Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of β-adrenoceptor blockade. J Hypertens 20:763-769
5. Meguro T, Hong C, Asai K, Takagi G, McKinsey TA, Olson EN, Vatner SF (1999) Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res 84:735-740
6. Nakamura A, Rokosh DG, Paccanaro M, Yee RR, Simpson PC, Grossman W, Foster E (2001) LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice. Am J Physiol 281:H1104-H1112
7. Oie E, Bjornerheim R, Clausen OP, Attramadal H (2000) Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am J Physiol 278:H2115-H2123
8. Sakata Y, Masuyama T, Yamamoto K, Nishikawa N, Yamamoto H, Kondo H, Ono K, Otsu K, Kuzuya T, Miwa T, Takeda H, Miyamoto E, Hori M (2000) Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. Circulation 102:2269-2275
9. Shimoyama M, Hayashi D, Takimoto E, Zou Y, Oka T, Uozumi H, Kudoh S, Shibasaki F, Yazaki Y, Nagai R, Komuro I (1999) Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 100:2449-2454
10. Yin FC, Spurgeon HA, Rakusan K, Weisfeldt ML, Lakatta EG (1982) Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 243:H941-H947